Pfizer to seek authorization for Covid-19 vaccine for children ages 2 to 11

Pfizer expects to file for full US Food and Drug Administration approval for its Covid-19 vaccine for people ages 16 to 85 this month, and will seek emergency use authorization for its vaccine for children ages 2 to 11 in September, the company said during an earnings call on Tuesday.

Leave a Reply

%d bloggers like this: